Liu Y, Ding J, Li S, Jiang A, Chen Z, Quan M
Cell Oncol (Dordr). 2025; .
PMID: 39903418
DOI: 10.1007/s13402-025-01038-9.
Perry C, Lavado A, Thulabandu V, Ramirez C, Pare J, Dixit R
bioRxiv. 2025; .
PMID: 39868115
PMC: 11760702.
DOI: 10.1101/2024.12.19.629472.
Tyrina E, Yakubets D, Markina E, Buravkova L
Cells. 2024; 13(22).
PMID: 39594669
PMC: 11592674.
DOI: 10.3390/cells13221921.
Tang Y, Chen F, Fang G, Zhang H, Zhang Y, Zhu H
EMBO J. 2024; 43(22):5586-5612.
PMID: 39358623
PMC: 11574045.
DOI: 10.1038/s44318-024-00257-4.
Mensah I, Gowher H
Genes (Basel). 2024; 15(6).
PMID: 38927734
PMC: 11202427.
DOI: 10.3390/genes15060798.
Maternal regulates zebrafish epiboly through Yap1 activity.
Camacho-Macorra C, Tabanera N, Sanchez-Bustamante E, Bovolenta P, Cardozo M
Front Cell Dev Biol. 2024; 12:1362695.
PMID: 38444829
PMC: 10912589.
DOI: 10.3389/fcell.2024.1362695.
The Effect of Long-Term Passage on Porcine SMCs' Function and the Improvement of TGF-β1 on Porcine SMCs' Secretory Function in Late Passage.
Zheng Y, Hu Z, Liu Z, Jiang Y, Guo R, Ding S
Foods. 2023; 12(14).
PMID: 37509774
PMC: 10378609.
DOI: 10.3390/foods12142682.
Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases.
Li R, Huang W
Int J Mol Sci. 2023; 24(2).
PMID: 36675179
PMC: 9861006.
DOI: 10.3390/ijms24021666.
Emerging Role of YAP and the Hippo Pathway in Prostate Cancer.
Koinis F, Chantzara E, Samarinas M, Xagara A, Kratiras Z, Leontopoulou V
Biomedicines. 2022; 10(11).
PMID: 36359354
PMC: 9687800.
DOI: 10.3390/biomedicines10112834.
TNS1: Emerging Insights into Its Domain Function, Biological Roles, and Tumors.
Wang Z, Ye J, Dong F, Cao L, Wang M, Sun G
Biology (Basel). 2022; 11(11).
PMID: 36358270
PMC: 9687257.
DOI: 10.3390/biology11111571.
The Hippo signalling pathway and its implications in human health and diseases.
Fu M, Hu Y, Lan T, Guan K, Luo T, Luo M
Signal Transduct Target Ther. 2022; 7(1):376.
PMID: 36347846
PMC: 9643504.
DOI: 10.1038/s41392-022-01191-9.
Integrating Genetic Alterations and the Hippo Pathway in Head and Neck Squamous Cell Carcinoma for Future Precision Medicine.
Ando T, Okamoto K, Shintani T, Yanamoto S, Miyauchi M, Gutkind J
J Pers Med. 2022; 12(10).
PMID: 36294681
PMC: 9604790.
DOI: 10.3390/jpm12101544.
Depletion of VGLL4 Causes Perinatal Lethality without Affecting Myocardial Development.
Sheldon C, Farley A, Ma Q, Pu W, Lin Z
Cells. 2022; 11(18).
PMID: 36139407
PMC: 9496954.
DOI: 10.3390/cells11182832.
Targeting the Hippo/YAP/TAZ signalling pathway: Novel opportunities for therapeutic interventions into skin cancers.
Howard A, Bojko J, Flynn B, Bowen S, Jungwirth U, Walko G
Exp Dermatol. 2022; 31(10):1477-1499.
PMID: 35913427
PMC: 9804452.
DOI: 10.1111/exd.14655.
Clinical potential of the Hippo-YAP pathway in bladder cancer.
Cheng X, Lou K, Ding L, Zou X, Huang R, Xu G
Front Oncol. 2022; 12:925278.
PMID: 35912245
PMC: 9336529.
DOI: 10.3389/fonc.2022.925278.
Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
Nishina H
Cancer Sci. 2022; 113(6):1900-1908.
PMID: 35349740
PMC: 9207356.
DOI: 10.1111/cas.15352.
Mutations and Copy Number Abnormalities of Hippo Pathway Components in Human Cancers.
He Z, Li R, Jiang H
Front Cell Dev Biol. 2021; 9:661718.
PMID: 34150758
PMC: 8209335.
DOI: 10.3389/fcell.2021.661718.
Biochemical properties of VGLL4 from Homo sapiens and Tgi from Drosophila melanogaster and possible biological implications.
Mesrouze Y, Meyerhofer M, Zimmermann C, Fontana P, Erdmann D, Chene P
Protein Sci. 2021; 30(9):1871-1881.
PMID: 34075638
PMC: 8376407.
DOI: 10.1002/pro.4138.
The Hippo pathway: Horizons for innovative treatments of peripheral nerve diseases.
Feltri M, Weaver M, Belin S, Poitelon Y
J Peripher Nerv Syst. 2021; 26(1):4-16.
PMID: 33449435
PMC: 8455061.
DOI: 10.1111/jns.12431.
The role of the Hippo pathway in the pathogenesis of inflammatory bowel disease.
Xie Z, Wang Y, Yang G, Han J, Zhu L, Li L
Cell Death Dis. 2021; 12(1):79.
PMID: 33436549
PMC: 7804279.
DOI: 10.1038/s41419-021-03395-3.